Actionable news
All posts from Actionable news
Actionable news in RPTP: Raptor Pharmaceutical Corp.,

Shkreli Thinks Raptor Pharmaceutical's Valuation Was Too Low

Raptor Pharmaceutical Corp. NASDAQ:RPTP, Horizon Pharma, Inc. NASDAQ:HZNP - Shkreli Thinks Raptor Pharmaceutical's Valuation Was Too Low

Shares of Raptor Pharmaceutical Corp. RPTP 20.34% were trading higher by more than 20 percent Monday after the company agreed to be acquired by Horizon Pharma PLC HZNP 4.2% for $800 million, or $9 per share.

Speaking as a guest on Monday's Premarket Prep, Martin Shkreli shared his take on the deal and discussed the industry as a whole.

Related Link: Raptor Jumps 20% After Horizon Pharma's $800 Million Takeover Agreement

According to Shkreli, the premium that Horizon Pharma paid to acquire Raptor was "pretty modest" and he was expecting a price tag on any acquisition deal should have been "a lot more."

As a whole, Shkreli doesn't see any "over exuberant" valuations in the space.

Shares of Raptor Pharma traded recently at $64.61, up about 8 percent on the day.

© 2016 Benzinga does not provide investment advice. All rights reserved.